Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, komentáře
PubMed
36599947
DOI
10.1038/s41574-022-00800-5
PII: 10.1038/s41574-022-00800-5
Knihovny.cz E-zdroje
- MeSH
- autoprotilátky * MeSH
- diabetes mellitus 1. typu * genetika MeSH
- lidé MeSH
- mutace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- komentáře MeSH
- práce podpořená grantem MeSH
- Názvy látek
- autoprotilátky * MeSH
Department of Paediatrics 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Paediatrics University Hospital Motol Prague Czech Republic
Zobrazit více v PubMed
Parviainen, A., But, A., Siljander, H., Knip, M. & Finnish Pediatric Register. Decreased incidence of type 1 diabetes in young Finnish children. Diabetes Care 43, 2953–2958 (2020). PubMed DOI
Harsunen, M. T. et al. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register. Diabetologia https://doi.org/10.1007/s00125-022-05834-y (2022). PubMed DOI PMC
Carlsson, A. et al. Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: lessons from a 5-year pediatric Swedish national cohort study. Diabetes Care 43, 82–89 (2020). PubMed DOI
Sumnik, Z. et al. Five years of improving diabetes control in Czech children after the establishment of the population-based childhood diabetes register ČENDA. Pediatr. Diabetes 21, 77–87 (2020). PubMed DOI
Colclough, K., Ellard, S., Hattersley, A. & Patel, K. Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of maturity-onset diabetes of the young. Diabetes 71, 530–537 (2022). PubMed DOI
Stankute, I. et al. Systematic genetic study of youth with diabetes in a single country reveals the prevalence of diabetes subtypes, novel candidate genes, and response to precision therapy. Diabetes 69, 1065–1071 (2020). PubMed DOI
Mirshahi, U. et al. Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts. Am. J. Hum. Genet. 109, 2018–2028 (2022). PubMed DOI PMC
Pöllänen, P. M. et al. Autoantibodies to N-terminally truncated GAD65(96-585): HLA associations and predictive value for type 1 diabetes. J. Clin. Endocrinol. Metab. 107, e935–946 (2022). PubMed DOI
Food and Drug Administration. FDA approves first drug that can delay onset of type 1 diabetes. FDA.gov https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-can-delay-onset-type-1-diabetes (2022).
Chiarelli, F., Rewers, M. & Phillip, M. Screening of islet autoantibodies for children in the general population: a position statement endorsed by the European Society for Paediatric Endocrinology. Horm. Res. Paediatr. 95, 393–396 (2022). PubMed DOI
